Skip to content

Long-lasting subjective effects of LSD in normal subjects

Yasmin Schmid, Matthias E. Liechti

Psychopharmacology September 16, 2017 DOI: 10.1007/s00213-017-4733-3 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cohort Peer reviewed
Sample size 16
Population Healthy participants
Intervention Lysergic acid diethylamide (LSD)
Dose 200 μg
Duration 12-month follow-up
Topics Anxiety LSD Mescaline
Keywords Mood Hallucinogen Clinical psychology Developmental psychology
Citations 234
Registration NCT01878942
Key findings A single dose of LSD in a safe setting produced subjectively meaningful and long-lasting positive effects on well-being and attitudes, with no negative effects reported.

Abstract

Rationale: Lysergic acid diethylamide (LSD) and other serotonergic hallucinogens can induce profound alterations of consciousness and mystical-type experiences, with reportedly long-lasting effects on subjective well-being and personality.

Methods: We investigated the lasting effects of a single dose of LSD (200 μg) that was administered in a laboratory setting in 16 healthy participants. The following outcome measures were assessed before and 1 and 12 months after LSD administration: Persisting Effects Questionnaire (PEQ), Mysticism Scale (MS), Death Transcendence Scale (DTS), NEO-Five Factor Inventory (NEO-FFI), and State-Trait Anxiety Inventory (STAI).

Results: On the PEQ, positive attitudes about life and/or self, positive mood changes, altruistic/positive social effects, positive behavioral changes, and well-being/life satisfaction significantly increased at 1 and 12 months and were subjectively attributed by the subjects to the LSD experience. Five-Dimensions of Altered States of Consciousness (5D-ASC) total scores, reflecting acutely induced alterations in consciousness, and Mystical Experience Questionnaire (MEQ30) total scores correlated with changes in well-being/life satisfaction 12 months after LSD administration. No changes in negative attitudes, negative mood, antisocial/negative social effects, or negative behavior were attributed to the LSD experience. After 12 months, 10 of 14 participants rated their LSD experience as among the top 10 most meaningful experiences in their lives. Five participants rated the LSD experience among the five most spiritually meaningful experiences in their lives. On the MS and DTS, ratings of mystical experiences significantly increased 1 and 12 months after LSD administration compared with the pre-LSD screening. No relevant changes in personality measures were found.

Conclusions: In healthy research subjects, the administration of a single dose of LSD (200 μg) in a safe setting was subjectively considered a personally meaningful experience that had long-lasting subjective positive effects.

Trial Registration: Registration identification number: NCT01878942.

In the evidence

This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.

  • A single 200 μg dose of LSD produced long-lasting positive effects on well-being and attitudes at 1 and 12 months, with no negative effects attributed to the experience.

    Synthesized

Comparable studies

Other observational and cohort studies on LSD for anxiety, most cited first.

Study Year Design Participants
Psychedelics not linked to mental health problems or suicidal behavior: A population study Randomly selected United States adults 2015 Observational cohort n = 135,095
LYSERGIC ACID DIETHYLAMIDE (LSD-25) Patients with depressive reactions 1952 Observational cohort n = 15
Peri-traumatic consumption of classic psychedelics is associated with lower anxiety and post-traumatic responses 3 weeks after exposure. Adult survivors of a single large-scale terrorist attack at a festival 2025 Observational cohort n = 343
Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland. Adults with treatment-resistant depressive and/or anxiety disorders 2026 Retrospective observational cohort n = 115
Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational Study Patients with treatment-resistant depression or anxiety disorders treated under... 2025 Retrospective observational study n = 30

Explore topics

By condition and practice